Clinical Trials on 急性髓性白血病/急性淋巴细胞白血病 in Korea, Democratic People's Republic of
总计207个结果
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology完全的
-
Seoul National University HospitalPharos iBio Co., Ltd.招聘中
-
Samsung Medical Center未知
-
Konkuk University Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National University Hospital; Seoul National University Hospital 和其他合作者主动,不招人
-
Samsung Medical Center未知
-
Asan Medical Center终止
-
Korea Otsuka Pharmaceutical Co., Ltd.主动,不招人
-
Ulsan University HospitalThe Korean Society of Hematology, AML/MDS Working Party未知
-
Cooperative Study Group A for Hematology未知
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology未知
-
Tehran University of Medical Sciences完全的
-
Seoul National University Hospital招聘中
-
Ulsan University HospitalThe Korean Society of Hematology CML working party未知
-
JW Pharmaceutical主动,不招人
-
Sanofi终止急性髓性白血病 | 急性淋巴细胞白血病法国, 大韩民国, 墨西哥, 丹麦, 挪威, 美国, 阿根廷, 巴西, 德国, 希腊, 匈牙利, 意大利, 荷兰, 秘鲁, 葡萄牙, 瑞典
-
Samsung Medical CenterJin Yang Pharmaceutical暂停
-
Asan Medical Center主动,不招人
-
Asan Medical Center终止
-
Sabz BiomedicalsGene Therapy Research Center, Shariati Hospital, Tehran University of Medical Sciences, Iran; Research Institute for Oncology- Hematology and Cell Therapy (RIOHCT), Tehran University of Medical Sciences, Iran尚未招聘复发性 B 细胞急性淋巴细胞白血病 (ALL) | 难治性 B 细胞急性淋巴细胞白血病 (ALL)伊朗伊斯兰共和国
-
Astellas Pharma Korea, Inc.招聘中具有 FMS 样酪氨酸激酶 (FLT3) 突变的急性髓性白血病大韩民国
-
Otsuka Pharmaceutical Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.完全的
-
Seoul National University Hospital招聘中
-
Institut de Recherches Internationales ServierADIR, a Servier Group company主动,不招人
-
Seoul National University Hospital完全的
-
Amgen终止复发/难治性急性髓系白血病 (AML)美国, 大韩民国, 澳大利亚, 日本, 德国, 加拿大